About Progenicare
Progenicare is a company based in Austin (United States) founded in 2008 was acquired by ISTO Biologics in June 2017.. Progenicare operates in a competitive market with competitors including Blue Rock Therapeutics, CellCarta, Impel Pharmaceuticals, Ascend and Shanghai Cell Therapy Group, among others.
- Headquarter Austin, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
ISTO Biologics
& 1 more
-
Employee Count
Employee Count
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Progenicare
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Progenicare
Progenicare has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include ISTO Biologics and Sheridan Capital Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sheridan Capital Partners is focused on healthcare private equity investments.
|
Founded Year | Domain | Location | |
|
Developer of treatments for cartilage and bone problems
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Progenicare
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Progenicare
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Progenicare Comparisons
Competitors of Progenicare
Progenicare operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Blue Rock Therapeutics, CellCarta, Impel Pharmaceuticals, Ascend and Shanghai Cell Therapy Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Stem cell therapies are developed for cardiovascular and neurological diseases.
|
|
| domain | founded_year | HQ Location |
Histopathology and genomics services are offered by the CRO.
|
|
| domain | founded_year | HQ Location |
Transformative therapies are developed and commercialized through specialized services.
|
|
| domain | founded_year | HQ Location |
Online insurance payments and premium financing are enabled for businesses.
|
|
| domain | founded_year | HQ Location |
Research and development services for cell therapy are provided.
|
|
| domain | founded_year | HQ Location |
Online supplier and developer of RNA based products
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Progenicare
Frequently Asked Questions about Progenicare
When was Progenicare founded?
Progenicare was founded in 2008.
Where is Progenicare located?
Progenicare is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
What does Progenicare do?
Progenicare was established in 2008 and is based in Austin, United States. Operations are centered in the biotechnology and healthcare sectors, where cell and gene therapy clinical products are developed and supplied. Orthopedic solution services are also delivered to address therapeutic and clinical requirements. The focus remains on supporting advancements in regenerative medicine through these specialized offerings.
Who are the top competitors of Progenicare?
Progenicare's top competitors include Blue Rock Therapeutics, Ascend and CellCarta.
Who are Progenicare's investors?
Progenicare has 2 investors. Key investors include ISTO Biologics, and Sheridan Capital Partners.